Fri 30 Oct 2026 International edition

Molecular Biology & Genomics Unlocking the Marsupial Genome: Groundbreaking Study Reveals Koalas Survived Ancient Climate Crises Long Before Human Arrival

Medical Biotechnology Decoding the Bovine Outbreak: How Scientists Unlocked the Mystery of H5N1 Bird Flu in U.S. Dairy Cattle

Medical Biotechnology Deep-Sea Immunology: How a Humble Sea Anemone Rewrites the Evolutionary History of Animal Immunity

Precision Medicine Breaking the Genetic Bottleneck: Japanese Researchers Revolutionize DNA Assembly Using Silver Nanoparticles

Pathology & Histology Breaking Barriers in Oncology: The Rise of Shock-Scattering Micro-Histotripsy-Aided Fine Needle Aspiration

Clinical Trials & Research PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review

Molecular Biology & Genomics Unlocking the Genetic Blueprint of an Ecological Nightmare: How Advanced Sequencing Solved the Mystery of the Brown Tree Snake

Biochemistry & Metabolomics Unlocking Nature’s Ancient Secret: How Animals Across the Planet Feed on Earth’s Original Bioplastics

Microbiology & Infectious Diseases Nature’s Ultimate Illusionist: Newly Discovered Ecuadorian Spider Mimics the Very Parasite That Destroys Its Own Kind

Biochemistry & Metabolomics Deep Time Unveiled: Exceptional Canadian Fossil Discovery Rewrites the Timeline of Early Animal Evolution

Healthcare News & Policy Natural Relief on the Horizon: Daily Peppermint Oil Supplementation Shown to Reduce Mildly Elevated Blood Pressure in Landmark Study

Bio-Research & Life Sciences Unlocking the 518-Million-Year-Old Genesis of Spider Fangs: A Paleontological Breakthrough

Archive

Tag: plummets

BioVie’s Stock Plummets 33% Following SUNRISE-PD Phase IIb Trial Data Release Utilizing Novel, Company-Created EPNIC-15 Endpoint

Clinical Trials & Research

BioVie’s Stock Plummets 33% Following SUNRISE-PD Phase IIb Trial Data Release Utilizing Novel, Company-Created EPNIC-15 Endpoint

Executive Overview In the high-stakes world of biopharmaceutical research, the line separating scientific innovation from investor skepticism is razor-thin. On...

8 Aug 2026